Edwards Lifesciences Corp (NYSE: EW) is 4.98% higher on its value in year-to-date trading and has touched a low of $58.93 and a high of $95.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EW stock was last observed hovering at around $78.10 in the last trading session, with the day’s loss setting it -0.38%.
Currently trading at $77.72, the stock is 1.82% and 5.52% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.06 million and changing -0.49% at the moment leaves the stock 9.42% off its SMA200. EW registered -11.57% loss for a year compared to 6-month gain of 7.84%. The firm has a 50-day simple moving average (SMA 50) of $73.6558 and a 200-day simple moving average (SMA200) of $71.0319.
The stock witnessed a 2.74% loss in the last 1 month and extending the period to 3 months gives it a 8.88%, and is 1.97% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.84% over the week and 1.10% over the month.
Edwards Lifesciences Corp (EW) has around 15800 employees, a market worth around $45.59B and $5.54B in sales. Current P/E ratio is 51.93 and Fwd P/E is 28.22. Profit margin for the company is 16.03%. Distance from 52-week low is 31.89% and -18.40% from its 52-week high. The company has generated returns on investments over the last 12 months (8.22%).
The EPS is expected to grow by 1.63% this year.
Edwards Lifesciences Corp (EW) Top Institutional Holders
1767.0 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 90.52% of the company’s shares. The shares outstanding are 586.20M, and float is at 574.68M with Short Float at 1.28%. Institutions hold 89.69% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 53.58 million shares valued at $4.95 billion. The investor’s holdings represent 8.8982% of the EW Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 50.98 million shares valued at $$4.71 billion to account for 8.4663 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.01 million shares representing 4.3197% and valued at over $2.4 billion, while ALLIANCEBERNSTEIN L.P. holds 3.3784 of the shares totaling 20.34 million with a market value of $1.88 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by Zovighian Bernard J,the company’sCEO. SEC filings show that Zovighian Bernard J sold 16,099 shares of the company’s common stock on May 30 ’25 at a price of $77.21 per share for a total of $1.24 million. Following the sale, the insider now owns 9564.0 shares.
Edwards Lifesciences Corp disclosed in a document filed with the SEC on Jun 03 ’25 that Zovighian Bernard J (CEO) sold a total of 967 shares of the company’s common stock. The trade occurred on Jun 03 ’25 and was made at $77.32 per share for $74772.0. Following the transaction, the insider now directly holds 8597.0 shares of the EW stock.
Still, SEC filings show that on Jun 03 ’25, Zovighian Bernard J (Officer) Proposed Sale 967 shares at an average price of $77.32 for $74772.0. The insider now directly holds shares of Edwards Lifesciences Corp (EW).
